Dementia, Alzheimers and Neurological Disorders

Ricardo B. Maccioni M.D., Ph.D. is a Professor of Neurology at the Medical School, and Professor of Neurosciences, University of Chile. He also serves as the Director of the Laboratory of Molecular Neurosciences, Scientific Director of the International Center for Biomedicine (ICC) and Senior Investigator of the Brain/Mind Program in Chile. He has served as Associate Professor at the University of Colorado Medical School, Denver, U.S.A. He received his doctoral degree in 1975, and was a postdoctoral fellow at the National Institutes of Health, the University of Colorado Health Sciences Center and a visiting scholar at and the Max Plank Institute for Biophysics in Germany. He is a world class scientist that has made some of the world leading contributions to the cell biology of neuronal cells and the study of Alzheimer’s disease. His discoveries on the role of tau protein in the pathogenesis of this disease, his neuroimmunomodulation theory of neurodegenerative disorders, the design of a new in vivo neuroimaging technology, novel biomarkers for its early diagnosis and innovative approaches for the treatment of this disease, are among his major contributions. On the basis of these and numerous other findings, he is considered among the leading investigators in Alzheimer´s disease. Dr. Maccioni was ranked among the three Chilean scientists with the highest impact factor in a recent study on science productivity. He has served as Associated Editor of the Journal of Alzheimer´s Disease, and the board of J. Alzheimer´s Reports, Journal of Neurochemistry, Therapeutic Advances in Chronic Diseases, Frontiers in Dementia and Archives of Medical Research. He is co-author with George Perry of the recent book “Current Hypotheses and Research Milestones in Alzheimer´s Disease”, among other 10 books in this medical field. Maccioni has made outstanding achievements in the training of 59 young scientist, and is the author of 146 publications in high-impact journals and 18 patents. His scientific findings are characterized by the innovative approaches to elucidate complex problems of modern medical research. He has received more than sixty research grants and several international prizes, including awards from the Alzheimer´s Association, the Milheim Foundation, Presidential Chair in Science, Chacellor´s medal of the University of Chile, and Doctor Honris causa at several universities. His leadership is further attested by being the founder of IMBO (Ibero-American Molecular Biology Organization), the Millennium Institute CBB, and the International Center for Biomedicine, a world class center of excellence. He has organized over forty international conferences with prominent neuroscientists from all over the world.He is a also member of the Innovation Circle of ICARE in Chile, the National Academy of Sciences, Scientific Director of Neuroinnovation and advisor for several important scientific institutions. He is also an elected member of the Danna Alliance for Brain Inititives

In the field of technological innovation he has made contributions in monitoring new molecules for the treatment of Alzheimer´s disease.

Ingolf Schimke has completed his Ph.D. at the age of 27 years from “Academia der Wissenschaften” of the German Democratic Republic and postdoctoral studies from “Humbold Universität zu Berlin” Medicine. Until 2014, he was Professor for Clinical Chemistry and Laboratory Medicine at the “Charité – Universitätsmedizin Berlin” and is presently Director of Research & Development at “Berlin Cures GmbH”. He has published more than 100 papers in reputed journals. He is serving as an editorial board member of reputed journals.

Autoantibodies, Autoimmune diseases, Dementia

I am Dr.Mojtaba Mafi M.D., Medical Doctor/ Physician, Graduate of Tehran university, School of Medicine with honour. I passed post graduate courses on Nutrition, Gastroenterology and hepatology, Obesity treatment and diabetes approved by Medical Sciences University successfully. I am associate of Iran Hepatitis Network and Gastroenterology and Hepatology research center, Middle East Liver Diseases Center (MELD). I studied on fatty liver and related metabolic disorders among Iranian families from 2015 and currently publishing the results of our study and research about fatty liver and hyperlipidemia, diabetes and nutrition as study director and clinician associate member of Hepatitis Network. I am reviewer of Hepatitis Monthly Journal and journal of Clinical and Translational Hepatology. I passed successfully more than 10 courses with certificates in Iranian association of gastroenterology and hepatology. One of my works on diabetes and fatty liver as a scientific article has been accepted in 4th International Conference on Diabetes and Its Treatments at Dubai 2018 for oral presentation and publication. I am organizing committee member and speaker of International Conference of Nutrition and Diet Imbalance, Indonesia, 2018. My article on fatty liver and metabolism has been accepted in International Conference on Gastroenterology and hepatology, Thailand 2018, for oral and poster presentation. I am verified reviewer and certified mentor of Publons academy in the field of Clinical Medicine and Hepatology. I am invited participant for International Conference of Translational Medicine, Hawaii, from editor in chief of American Journal of Translational Medicine. I am invited speaker of International Conference on Obesity and Chronic diseases, 2018 in Dubai.

Hepatology, Liver Diseases, Gastroenterology

Asghar Zaidi is a Senior Research Fellow at the Oxford Institute of Population Ageing. Asghar Zaidi is Professor of Gerontology at Seoul National University, Korea and Visiting Professor at London School of Economics and Political Science, London. Previously, he was Professor in International Social Policy at University of Southampton (UK); Director Research at European Centre Vienna (Austria); Senior Economist at OECD Paris; Civil Servant at UK’s Department for Work and Pensions in London; and Researcher at London School of Economics, University of Oxford, Erasmus University and Tilburg University. His research spans measurement of active and healthy ageing, the wellbeing of older persons and those with disabilities and data on ageing and older persons. Since 2012, he has led the research work of the Active Ageing Index Project for the European Commission and UNECE and the Global AgeWatch Index project for HelpAge International. He has also developed the Wellbeing in Later Life Index for the UK, working alongside Age UK London. He has recently completed projects on human rights of older persons (for British Council Islamabad) and on dementia in Pakistan (for Age International UK). He is a Steering Committee member of the ASEM Global Ageing Centre and a member of the Core Group of the Titchfield City Group on Ageing.

Gerontology. Aging

Miia Kivipelto studied medicine at the University of Kuopio, became a registered medical doctor in 1999, and subsequently a specialist in geriatrics. She started to conduct research and gained her PhD in 2002 in Kuopio with a thesis on vascular risk factors with Alzheimer's disease. Between 2002 and 2005 Miia Kivipelto did her postdoc at Karolinska Institutet, KI, after which she worked at KIs Alzheimer's Centre, and at the Aging Research Center, ARC, since 2009 as a deputy section director. She is also a deputy director of the clinical trial unit at the Memory Clinic at Karolinska University Hospital in Huddinge. In 2006 Miia Kivipelto became an associate professor of neuroepidemiology and a research director at the University of Kuopio with support from the Academy of Finland and other sources. In 2010 she became a senior lecturer at KI. She has previously worked on assignments for the Swedish Council on Health Technology Assessment (SBU) and the National Board of Health and Welfare. Miia Kivipelto has been the recipient of numerous prizes. In 2009 she was awarded the Academy of Finland Award for Social Impact, and in 2011 the Junior Chamber International Award as Outstanding Young Person, in Finland and Internationally. Miia Kivipelto was appointed professor of clinical geriatric epidemiology at Karolinska Institutet in 2011.

Dementia and its risk factors, Neurogeriatrics, Age related diseases

Professor P. Giannakopoulos completed his medical studies at the University of Athens where he graduated in 1988. His psychiatric training was performed clinically in London (Maudsley Hospital) Geneva and Paris (Pité-Salpêtrière). It is FMH specialist in psychiatry in adults and the elderly. His research interests neuroscience of aging and Alzheimer's disease. Author of more than 170 items appraised, it is also the editor of four books, including a psychiatric abstract of the advanced age and many monographs. He is Professor and Department Head, Department of the Geneva University Hospitals of Psychiatry since 1998. Promoted to full professor in 2004, he is head of the Department of Psychiatry Hospital and assistant dean in charge of postgraduate education in the Faculty of Medicine. As part of its commitment to Lake Geneva psychiatry of old age, it is also Professor of Psychiatry and Director of the Academic Department of Psychiatry of Advanced Age Hospices-CHUV. Since 2006, he serves on the Executive Committee and the Board of Directors of the HUG (University Hospitals of Geneva). In 2008, he received the distinction of Commander of the Order of the Phoenix in his country of origin.

Neuroscience of aging and Alzheimer's Disease

She is a Swedish Research Council Senior Researcher in Psychiatric Epidemiology, and coordinates a Neuropsychiatric Epidemiology and Genetics research group in Sweden. She was the first to report on a relationship between overweight and risk of Alzheimer's disease in 2003 based on population-based studies in Sweden. She continues to explore adiposity, as well as vascular and metabolic factors, in relationship to neuropsychiatric disorders and age-related brain changes, with an evolving focus on underrepresented populations. She is a member of several collaborative research groups in the US, Europe, and South America with this focus. For example, she is a Work Package Leader for the multi-national and translational European Union project, Lipididiet, which investigates omega-3 fatty acids, cholesterol, and adiposity in cerebrovascular disease and Alzheimer’s disease. Adipose tissue hormones in relationship to dementia and cognition are a theme of her research, and she has obtained funding from multiple sources to investigate this hypothesis in populations of Swedish elderly, women with HIV/AIDS (WIHS), and individuals with Type 2 diabetes mellitus (ACCORD/MIND). Funding for these analyses comes from the Swedish Brain Power Project, NIH/NIAID, and NIH/NIA. Also, she is PI of an NIH/NARCH pilot project, the Heart Mind Study, in Southwest tribes (New Mexico), which assesses cardiovascular factors in cognitive and depressive disorders. Through collaborations in Buenos Aires, Argentina and Treviso, Italy, similar initiatives are pursued. She has over 70 peer-reviewed or invited publications, and she is an invited speaker at international meetings on the topics of adiposity, vascular factors, and prevention of dementia and other psychiatric disorders in the elderly. In 2009, she was elected to the Executive Committee of the International Society for Vascular and Cognitive Impairment (Vas-Cog), co-founded the Women in Dementia Research group within Vas-Cog, and an Invited delegate and speaker to the International Association of Gerontology and Geriatrics, World Health Organization and Société Francaise de Gériatrie et de Gérontologie workshop entitled, ‘Health promotion program on prevention of late onset dementia’ in Geneva in 2011. She received her educational training from the University of Minnesota, USA, and held an NIH postdoctoral fellowship.

Neuropsychiatric disorders, Age-related brain changes, Psychiatric Epidemiology, Dementia and Cognition

Jose Alejandro Luchsinger received his MD degree from the Universidad Central de Venezuela in Caracas. He completed an internal medicine residency program including one year as Chief Medical Resident at St. Luke's Hospital in New York City. He also completed a General Medicine Fellowship at CUMC and obtained an MPH in epidemiology from the Mailman School of Public Health at CUMC. He has been a faculty member since 1999. His research has focused on the relation of vascular, metabolic, and dietary on aging outcomes, primarily cognition, in diverse populations. He conducts cohort studies and clinical trials. He is the director of the Center on Aging and Health Disparities (CAHD) in the Division of General Medicine. The CAHD is the home for the Northern Manhattan Center of Excellence in Minority Health and Health Disparities at Columbia University, funded by NIMHD, and various research projects in aging, minority health, and health disparities.

Risk factors for cognitive impairment and aging, Relationship between cardiovascular risk factors and cognition, Relationship between diet and cognition

Dr. Ahmet Turan ISIK finished his graduation from Gulhane Military Medical Academy in 1995. He received specialist training in internal medicine in 2002 and became a specialist in internal medicine. In 2007, He completed geriatric side branch education and became a geriatrician. He had completed postgraduate studies both in the country and abroad on cognitive disorders and dementia (dementia) syndromes, especially Alzheimer's disease in the ages. He received associate professor position on December 2006 and Professor Title on March 2012. He is currently serving as the Head of the Department of Geriatrics at Dokuz Eylül University Medical Faculty. He is also a part-time faculty member at the Faculty of Health Sciences of Eastern Mediterranean University. His research interests reflect in his wide range of publications in various national and international journals. He is also author of many international books.

Cognitive Impairment in The Older Adults, Drug effects, Insulin resistance in the patients with dementia, Late Onset Alzheimer's Disease, Experimental Neurodegenerative Disease, Stem cell therapy in Neurodegenertive disease Geriatrics,

Dr. Ken Nagata is currently a director of Clinical Research Institute, Yokohama General Hospital, Yokohama, Japan. He was graduated from Hirosaki University School of Medicine in 1978, and had neurology training at Mihara Memorial Hospital. He received a Ph.D. degree from Hirosaki University in 1988. He was a visiting assistant professor at the Department of Neurology, University of Colorado Health Sciences Center in Denver, USA in 1983-1984. He is a founding chairman of the Japanese Vas-Cog Society, and hosted the Vas-Cog World Congress 2015 in Tokyo. His main interests include cerebrovascular disease, dementia and neuroimaging.

Cerebrovascular Disease, Dementia, Neuroimaging

1983 Department of Biology, Nanjing University, received a bachelor's degree in human and animal physiology; 1986 Chinese Academy of Sciences Shanghai Institute of Physiology physiology master's degree in physiology; 1989 New York State University of Psychology and neuroscience professional doctorate in psychology; He studied at the Rudolf Magnus Prize at the Royal Academy of Sciences in the Netherlands and studied at the National Institutes of Health (NIH) Mental Health (NIMH) and the Institute of Neurology and Stroke (NINDS) for postdoctoral and assistant researchers; He is a member of the Neuroimmunology Exploratory Group (Neuroimmunology Exploratory Group), a team leader and senior molecular neuropharmacologist at the Abbott Labs Department of Neuroscience. In 1997, he worked at the Sun City Medical Health Institute in Arizona (LJ Roberts Center for Alzheimer's Disease) Director and Senior Scientist and Associate Professor of Molecular Cell Biology at Arizona State University; Mans and cell neurons Director of the laboratory, senior scientist and molecular biology professor; in 2006 as the United States Sun Health Asia Pacific Medical Research Center co-director; in 2010 joined the Florida Rosemount Medical Institute as brain disease and treatment strategy research and treatment center director , A senior scientist and professor of neurology at the Faculty of Medicine of the University of Florida. In 2014, he was selected as a "Thousand Talents Program" scholar and returned to China University of Science and Technology in the same year. Received a number of awards and honors, including the "Zenith Award" and "Outstanding Contributor to Alzheimer Research" in the field of Alzheimer's disease. Published a total of more than 100 articles on neurodevelopmental diseases, neurotransmitter new receptor molecular cloning and pharmacological identification, neurodegenerative disease molecular mechanism and pathology, neuroimmunology and other aspects of the article (Nature Medicine, Journal of Cell Biology, Cell Molecular Cell, JAMA Psychiatry, Neuron, Proc. Natl. Acad. Sci. USA, Brain, Neurology, Journal of Neuroscience, International Journal.

(1) molecular mechanisms of neurodegenerative diseases and psychiatric disorders, including gene expression regulation and discovery of new genes in the brain; (2) molecular pathology identification and drug discovery of neurodegenerative diseases and psychiatric therapeutic targets; and (3) ) Clinical diagnosis of brain disease.

Dr.Jera KRUJA is a Member of Scientific Committee at European Academy of Neurology and Professor of Neurology at Mother Theresa University Hospital Center. Since 2014 she is (European representative) at Teaching Course Committee, World Federation of Neurology. During 2013-2014 she is a Rector of University of Medicine, Tirana and Member of editing board of OA Publishing London, WebMed Central Brain Editor, Albanian Medical Journal, Bulletin of Medical Sciences, University of Medicine, Tirana. She worked at Health National Contact Point, European Commission, CORDIS Fp7 programme(2010-2013). From 2003, she is a reviewer of European Journal of Neurology, Clinical Epidemiology, Neuropsychiatric Disease and Treatment, Journal of Epidemiology and Community Health, Journal of Pediatric Epilepsy. She is a Trainer of European Academy of Epilepsy since February 2003. She is the President of Albanian Society of Neurology (ASN) during 1998-2007.

Neurology, Neuroradiology, Epidemiology

He is awarded MD in General Medicine from Manipal University, Kasturba Medical College, India in 2011. He holds a Master Degree (MSc) in Health Care Management in Quality & Patient Safety from Royal College of Surgeons (RCSI), Dublin, Ireland in March 2017, followed by a Bachelor’s Degree MBBS from Mahatma Gandhi University, Govt. Medical College, India in the 2005. Currently, he is working as an Assistant Professor for Weill Cornell Medical College, Qatar and Honorary Specialist Geriatrics in Medicine at Hamad Medical Corporation, Qatar. His international experience includes various programs, contributions and participation in different countries for diverse fields of study. His research interests reflect in his wide range of publications in various national and international journals. He is the Editorial Board Member of Medical Case Reports Journal, Annals of Geriatric Education and Medical Sciences, Diabetes and Metabolism Journal and serves as a member of various associations such as American Geriatrics Society, American College of Physicians, European Academy of Aging Medicine, apart from being an author for many.

Neurology, Neurodegenerative Disorders, Aging-associated disease, Elderly Care Practices

Dr Meguro was educated at the Tohuku University at both undergraduate and post-graduate level. He obtained his PhD in Neurology and Geriatric Medicine. He has vast work experiences at the Centre-CYCERON-INSERM, in France and the ADRC, Washington University in St. Louis, School of Medicine. From 2005 till present, he is a Professor at the Department of Geriatric Behavioral Neurology, Tohoku University Graduate School of Medicine. He is board-certified by the Japanese Academic Societies in the specialty of Internal Medicine, Clinical Neurology, Stroke Medicine, Geriatric Psychiatry, Dementia Medicine. He sat on the editorial Board of prestigious journal such as the Alzheimer Disease Associated Disorders, Dementia & Neuropsychology and the International Journal of Alzheimer’s Disease

Dementia, Alzheimer's disease related disorders, Neuropsychology